AAPL   319.55 (+0.21%)
MSFT   182.87 (-0.35%)
FB   235.07 (+0.07%)
GOOGL   1,435.00 (+1.54%)
NVDA   351.61 (-2.61%)
BABA   202.80 (+1.55%)
MU   46.48 (+3.43%)
GE   6.88 (+7.33%)
TSLA   820.82 (+0.48%)
AMD   54.28 (-1.61%)
ACB   15.73 (-1.75%)
F   5.84 (+3.18%)
GILD   74.15 (+1.09%)
DIS   122.11 (+3.47%)
NFLX   415.19 (-3.29%)
BAC   24.39 (+7.63%)
BA   145.66 (+5.91%)
AAPL   319.55 (+0.21%)
MSFT   182.87 (-0.35%)
FB   235.07 (+0.07%)
GOOGL   1,435.00 (+1.54%)
NVDA   351.61 (-2.61%)
BABA   202.80 (+1.55%)
MU   46.48 (+3.43%)
GE   6.88 (+7.33%)
TSLA   820.82 (+0.48%)
AMD   54.28 (-1.61%)
ACB   15.73 (-1.75%)
F   5.84 (+3.18%)
GILD   74.15 (+1.09%)
DIS   122.11 (+3.47%)
NFLX   415.19 (-3.29%)
BAC   24.39 (+7.63%)
BA   145.66 (+5.91%)
AAPL   319.55 (+0.21%)
MSFT   182.87 (-0.35%)
FB   235.07 (+0.07%)
GOOGL   1,435.00 (+1.54%)
NVDA   351.61 (-2.61%)
BABA   202.80 (+1.55%)
MU   46.48 (+3.43%)
GE   6.88 (+7.33%)
TSLA   820.82 (+0.48%)
AMD   54.28 (-1.61%)
ACB   15.73 (-1.75%)
F   5.84 (+3.18%)
GILD   74.15 (+1.09%)
DIS   122.11 (+3.47%)
NFLX   415.19 (-3.29%)
BAC   24.39 (+7.63%)
BA   145.66 (+5.91%)
AAPL   319.55 (+0.21%)
MSFT   182.87 (-0.35%)
FB   235.07 (+0.07%)
GOOGL   1,435.00 (+1.54%)
NVDA   351.61 (-2.61%)
BABA   202.80 (+1.55%)
MU   46.48 (+3.43%)
GE   6.88 (+7.33%)
TSLA   820.82 (+0.48%)
AMD   54.28 (-1.61%)
ACB   15.73 (-1.75%)
F   5.84 (+3.18%)
GILD   74.15 (+1.09%)
DIS   122.11 (+3.47%)
NFLX   415.19 (-3.29%)
BAC   24.39 (+7.63%)
BA   145.66 (+5.91%)
Log in

NASDAQ:IMGNImmunoGen Earnings Date, Estimates & History

$5.07
-0.19 (-3.61 %)
(As of 05/26/2020 02:05 PM ET)
Add
Compare
Today's Range
$5.05
Now: $5.07
$5.28
50-Day Range
$3.39
MA: $4.01
$5.34
52-Week Range
$1.76
Now: $5.07
$7.07
Volume93,929 shs
Average Volume2.56 million shs
Market Capitalization$884.26 million
P/E RatioN/A
Dividend YieldN/A
Beta2.3

Earnings

ImmunoGen (NASDAQ:IMGN) Earnings Information

ImmunoGen last announced its earnings results on May 1st, 2020. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.02. The business earned $13.29 million during the quarter, compared to the consensus estimate of $14.53 million. ImmunoGen has generated ($0.70) earnings per share over the last year. ImmunoGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 7th, 2020 based off prior year's report dates.

ImmunoGen Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ImmunoGen (NASDAQ:IMGN) Earnings Estimates

2020 EPS Consensus Estimate: ($1.02)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.33)($0.16)($0.25)
Q2 20203($0.34)($0.18)($0.26)
Q3 20203($0.30)($0.22)($0.26)
Q4 20203($0.39)($0.13)($0.26)
Q1 20211($0.07)($0.07)($0.07)
Q2 20211($0.09)($0.09)($0.09)
Q3 20211($0.09)($0.09)($0.09)

ImmunoGen (NASDAQ IMGN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/7/2020
(Estimated)
       
5/1/20203/31/2020($0.15)($0.17)($0.17)$14.53 million$13.29 millionTranscript
2/14/2020Q4 2019($0.05)$0.0324$0.03$29.24 million$44.86 millionTranscript
11/1/2019Q3 2019($0.19)($0.15)($0.15)$10.38 million$13.30 millionTranscript
8/2/20196/30/2019($0.32)($0.29)($0.29)$10.33 million$15.54 millionListen
5/3/20193/31/2019($0.31)($0.30)($0.30)$10.59 million$8.60 millionN/A
2/8/201912/31/2018($0.33)($0.2750)($0.28)$12.42 million$13.79 millionListen
11/2/20189/30/2018($0.33)($0.32)($0.30)$13.60 million$10.90 millionN/A
7/27/2018Q2 2018($0.29)($0.31)($0.29)$14.12 million$9.29 millionN/A
5/4/2018Q1 2018($0.27)($0.30)($0.30)$15.04 million$19.80 millionN/A
2/9/2018Q4 2017($0.07)($0.10)($0.09)$39.62 million$39.40 millionTranscript
11/3/2017Q3 2017($0.19)($0.61)($0.13)$26.09 million$8.50 millionN/A
7/28/2017Q2 2017($0.1660)($0.10)($0.10)$30.59 million$39.02 millionN/A
5/5/20173/31/2017($0.36)($0.20)($0.20)$16.16 million$28.70 millionN/A
2/17/2017Q2 2017($0.39)($0.39)($0.39)$16.28 million$13.85 millionListen
10/28/2016Q117($0.38)($0.51)($0.41)$21.12 million$7.66 millionListen
8/4/2016Q416($0.39)($0.51)($0.51)$17.11 million$7.41 millionListen
4/29/2016Q316($0.31)($0.37)($0.37)$23.02 million$19.71 millionListen
1/29/2016Q216($0.36)($0.38)($0.38)$19.54 million$18.03 millionListen
10/27/2015Q116($0.35)($0.39)($0.39)$15.84 million$14.90 millionListen
7/31/2015Q415($0.34)($0.35)($0.35)$15.42 million$12.61 millionListen
4/24/2015Q315($0.25)($0.25)($0.25)$20.95 million$11.40 millionListen
1/30/2015Q215($0.06)$0.16$0.16$37.30 million$48.30 millionListen
10/24/2014Q115($0.14)($0.26)($0.26)$21.80 million$13.20 millionListen
8/1/2014Q414($0.36)($0.31)($0.31)$9.72 million$5.74 millionN/A
4/25/2014Q314($0.27)($0.44)($0.14)$13.28 million$6.90 millionTranscript
1/31/2014Q4 2013($0.19)$0.04$0.04$18.16 million$30.10 millionListen
10/25/2013Q3 2013($0.22)($0.13)($0.13)$12.10 million$17.20 millionTranscript
8/2/2013Q2 2013($0.30)($0.26)($0.26)$3.44 million$3.83 millionN/A
4/26/2013Q1 2013($0.14)($0.02)($0.02)$11.94 million$25.00 millionTranscript
1/25/2013Q2 2013($0.25)($0.29)$6.02 million$2.60 millionN/A
10/26/2012Q113($0.25)($0.30)$4.10 million$4.10 millionN/A
8/3/2012($0.30)($0.29)N/A
4/27/2012($0.26)($0.24)Transcript
1/27/2012($0.22)($0.17)N/A
10/27/2011($0.22)($0.26)N/A
8/3/2011($0.24)($0.23)N/A
4/28/2011Q1 2011($0.23)($0.22)($0.22)N/A
1/27/2011Q4 2010($0.22)($0.21)($0.21)N/A
10/28/2010Q3 2010($0.23)($0.19)($0.19)N/A
8/4/2010Q2 2010($0.24)($0.21)($0.21)N/A
4/29/2010Q1 2010($0.23)($0.21)($0.21)N/A
1/28/2010Q4 2009($0.21)($0.23)($0.23)N/A
10/29/2009Q3 2009($0.20)($0.22)($0.22)N/A
8/6/2009Q2 2009($0.17)($0.21)($0.21)N/A
4/30/2009Q1 2009($0.10)($0.09)($0.09)N/A
1/29/2009Q4 2008($0.15)($0.14)($0.14)N/A
10/27/2008Q3 2008($0.21)($0.19)($0.19)N/A
8/7/2008Q2 2008($0.25)($0.27)($0.27)N/A
5/1/2008Q1 2008($0.21)($0.30)($0.30)N/A
1/31/2008Q4 2007($0.11)($0.15)($0.15)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.